Published in Radiat Med on October 01, 2006
Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol (2009) 0.93
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective. J Contemp Brachytherapy (2014) 0.93
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med (2010) 27.12
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol (2011) 2.79
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer (2009) 2.35
Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study. Lancet Oncol (2008) 1.87
A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. Clin Pharmacol Ther (2003) 1.84
Respiration tracking in radiosurgery. Med Phys (2004) 1.67
Acute renal failure likely due to acute nephritic syndrome associated with typhoid fever. Intern Med (2005) 1.62
Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol (2005) 1.60
Clinical characteristics of pleomorphic carcinoma of the lung. Lung Cancer (2009) 1.55
Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration (2008) 1.48
Poorly differentiated neuroendocrine carcinoma of the seminal vesicle. Int J Urol (2011) 1.40
Mice deficient in the axonemal protein Tektin-t exhibit male infertility and immotile-cilium syndrome due to impaired inner arm dynein function. Mol Cell Biol (2004) 1.29
Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape. Inflammation (2010) 1.27
Plasmacytoid urothelial carcinoma of the bladder. Int J Urol (2006) 1.25
Solution of the structure of the TNF-TNFR2 complex. Sci Signal (2010) 1.25
Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials (2011) 1.25
The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture. Biomaterials (2010) 1.21
Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res (2004) 1.21
Proximal pulmonary artery aneurysms in patients with pulmonary artery hypertension: complicated cases. Intern Med (2007) 1.18
Site-specific PEGylation of a lysine-deficient TNF-alpha with full bioactivity. Nat Biotechnol (2003) 1.13
Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol (2002) 1.12
A prospective PCR-based screening for the EML4-ALK oncogene in non-small cell lung cancer. Clin Cancer Res (2012) 1.12
A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Int J Radiat Oncol Biol Phys (2009) 1.11
Effect of gefitinib re-challenge to initial gefitinib responder with non-small cell lung cancer followed by chemotherapy. Lung Cancer (2009) 1.11
Laparoscopic totally extraperitoneal inguinal hernia repair: twenty-seven serious complications after 4565 consecutive operations. Rev Col Bras Cir (2013) 1.10
Mouse germ cell-less as an essential component for nuclear integrity. Mol Cell Biol (2003) 1.09
Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study. Radiother Oncol (2013) 1.07
Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist. J Biol Chem (2007) 1.06
Clinical outcome and prognostic factors of sorafenib in Japanese patients with advanced renal cell carcinoma in general clinical practice. Jpn J Clin Oncol (2011) 1.06
Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol (2003) 1.05
DIBAL-mediated reductive transformation of trans-dimethyl tartrate acetonide into ε-hydroxy α,β-unsaturated ester and its derivatives. J Org Chem (2011) 1.05
Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B. Biochem Biophys Res Commun (2010) 1.05
Malignant melanoma arising from cutaneous bronchogenic cyst of the scapular area. J Am Acad Dermatol (2002) 1.04
Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J Exp Med (2003) 1.04
Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part Fibre Toxicol (2011) 1.03
Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan. Univariate analysis of JACC study data. Kurume Med J (2004) 1.03
Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant. J Mol Biol (2008) 1.03
Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice. Part Fibre Toxicol (2013) 1.03
Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res (2010) 1.03
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology (2012) 1.02
Development of PEGylated adenovirus vector with targeting ligand. Int J Pharm (2007) 1.02
Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study. Lung Cancer (2010) 1.02
Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer (2009) 1.01
Interleukin-1 family cytokines as mucosal vaccine adjuvants for induction of protective immunity against influenza virus. J Virol (2010) 1.00
High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys (2003) 1.00
Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol (2009) 1.00
Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol (2012) 0.99
Color auto-fluorescence from cancer lesions: improved detection of central type lung cancer. Lung Cancer (2007) 0.99
Brachytherapy for early oral tongue cancer: low dose rate to high dose rate. J Radiat Res (2003) 0.99
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys (2012) 0.99
Cancer and pulmonary embolism: thrombotic embolism, tumor embolism, and tumor invasion into a large vein. Circ J (2006) 0.99
Delusion of oral parasitosis and thalamic pain syndrome. Psychosomatics (2009) 0.99
Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration. J Control Release (2007) 0.99
Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer (2010) 0.98
Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience. Int J Gynecol Cancer (2013) 0.98
Concurrent weekly nedaplatin, external beam radiotherapy and high-dose-rate brachytherapy in patients with FIGO stage IIIb cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol Obstet Invest (2010) 0.97
Dietary unripe apple polyphenol inhibits the development of food allergies in murine models. FEBS Lett (2005) 0.97
Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part Fibre Toxicol (2012) 0.96
Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases. Gynecol Oncol (2010) 0.96
The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF. Biomaterials (2009) 0.96
Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett (2011) 0.96
Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide. Biochem Biophys Res Commun (2007) 0.96
O2 and reactive oxygen species detoxification complex, composed of O2-responsive NADH:rubredoxin oxidoreductase-flavoprotein A2-desulfoferrodoxin operon enzymes, rubperoxin, and rubredoxin, in Clostridium acetobutylicum. Appl Environ Microbiol (2009) 0.95
Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy. Radiat Med (2006) 0.95
Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome. Anticancer Res (2007) 0.95
The use of PVP as a polymeric carrier to improve the plasma half-life of drugs. Biomaterials (2004) 0.94
High dose rate brachytherapy for oral cancer. J Radiat Res (2012) 0.94
Development of amphiphilic gamma-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier. Biochem Biophys Res Commun (2007) 0.93
Characterization of lymphangiogenesis in various stages of idiopathic diffuse alveolar damage. Hum Pathol (2009) 0.93
The TheraCyte™ device protects against islet allograft rejection in immunized hosts. Cell Transplant (2012) 0.93
Radiotherapy targeting cancer stem cells: current views and future perspectives. Anticancer Res (2013) 0.92
Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecol Oncol (2011) 0.92
Phase II study of gefitinib readministration in patients with advanced non-small cell lung cancer and previous response to gefitinib. Oncology (2011) 0.92
Cardiac-sparing radiotherapy for the left breast cancer with deep breath-holding. Jpn J Radiol (2009) 0.92
Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus. J Mol Biol (2008) 0.92
The targeting of anionized polyvinylpyrrolidone to the renal system. Biomaterials (2004) 0.91
Gemstone spectral imaging: determination of CT to ED conversion curves for radiotherapy treatment planning. J Appl Clin Med Phys (2013) 0.91
Macrophages participate in lymphangiogenesis in idiopathic diffuse alveolar damage through CCL19-CCR7 signal. Hum Pathol (2009) 0.91
Characteristics of heart failure associated with the Great East Japan Earthquake. J Cardiol (2013) 0.91
Suppression of nanosilica particle-induced inflammation by surface modification of the particles. Arch Toxicol (2012) 0.91
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models. Cytokine (2008) 0.91
Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion. J Radiat Res (2012) 0.90
Morphology, structure of dimorphic sperm, and reproduction in the hermaphroditic commensal bivalve Pseudopythina tsurumaru (Galeommatoidea: Kellidae). J Morphol (2004) 0.90
Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease. Respiration (2003) 0.90
Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting. Nat Biotechnol (2003) 0.89
Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma. Int J Radiat Oncol Biol Phys (2009) 0.89
Levels of physical activity among participants in the JACC study. J Epidemiol (2005) 0.89
[A case of effective chemoradiation therapy against anal fistula carcinoma recurred 10 years after surgery]. Gan To Kagaku Ryoho (2006) 0.89
Effectiveness of cervical cancer screening over cervical cancer mortality among Japanese women. Jpn J Clin Oncol (2006) 0.88
Occurrence of cardiovascular events after the 2011 Great East Japan Earthquake and tsunami disaster. Int Heart J (2013) 0.88
Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterials. Biomaterials (2010) 0.88
Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. Cell Transplant (2008) 0.88
A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. Eur J Cancer (2011) 0.88
Therapeutic effect of PEGylated TNFR1-selective antagonistic mutant TNF in experimental autoimmune encephalomyelitis mice. J Control Release (2009) 0.87
CyberKnife stereotactic irradiation for metastatic brain tumors. Radiat Med (2003) 0.87
Quantitative analysis for computed tomography findings of various diffuse lung diseases using volume histogram analysis. J Comput Assist Tomogr (2006) 0.87
Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer. Eur J Cancer (2005) 0.87
Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2011) 0.87
Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol (2011) 0.87